Market Capitalization (Millions $) |
26 |
Shares
Outstanding (Millions) |
65 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-70 |
Cash Flow (TTM) (Millions $) |
-53 |
Capital Exp. (TTM) (Millions $) |
2 |
Applied Genetic Technologies Corporation
Applied Genetic Technologies Corporation (AGTC) is a biotechnology company that develops gene therapies to treat genetic disorders. The company utilizes its expertise in the field of adeno-associated virus (AAV) vectors to deliver genes to specific cells and tissues in the body. AGTC focuses on developing treatments for rare ophthalmic diseases, including inherited retinal disorders, such as X-linked retinoschisis and achromatopsia. The company's goal is to improve the quality of life for patients suffering from these disorders by providing effective and long-lasting gene therapies. AGTC is committed to advancing the field of gene therapy and conducting clinical trials to evaluate the safety and efficacy of its treatments.
Company Address: 14193 NW 119th Terrace, Suite 10 Alachua 32615 FL
Company Phone Number: 462-2204 Stock Exchange / Ticker: NASDAQ AGTC
|